3-tyr-octreotide has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eltschinger, V; Reubi, JC; Schottelius, M; Schwaiger, M; Wester, HJ | 1 |
| Decristoforo, C; Mather, SJ | 1 |
2 other study(ies) available for 3-tyr-octreotide and Experimental Neoplasms
| Article | Year |
|---|---|
N-terminal sugar conjugation and C-terminal Thr-for-Thr(ol) exchange in radioiodinated Tyr3-octreotide: effect on cellular ligand trafficking in vitro and tumor accumulation in vivo.
Topics: Animals; Biological Transport; Cell Line; Cricetinae; Cricetulus; Female; Glucose; Glycosylation; Humans; Iodine Radioisotopes; Isotope Labeling; Ligands; Maltose; Mice; Mice, Nude; Neoplasms, Experimental; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Structure-Activity Relationship; Trisaccharides | 2005 |
Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence.
Topics: Animals; Chelating Agents; Edetic Acid; Isotope Labeling; Male; Neoplasms, Experimental; Octreotide; Radionuclide Imaging; Rats; Rats, Wistar; Somatostatin; Technetium; Tissue Distribution | 1999 |